Ovintiv Inc. (OVV)

Positive revenue growth while OBE is negative. John Neff might see a notable competitive edge here.

Positive EBIT growth while OBE is negative. John Neff might see a substantial edge in operational management.

Positive net income growth while OBE is negative. John Neff might see a big relative performance advantage.

Positive EPS growth while OBE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.

Positive diluted EPS growth while OBE is negative. John Neff might view this as a strong relative advantage in controlling dilution.

Share reduction while OBE is at 3.38%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.

Reduced diluted shares while OBE is at 0.02%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.

Dividend growth of 7.28% while OBE is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.

Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.

Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.

Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.

Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.

Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.

Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.

Positive 10Y CAGR while OBE is negative. John Neff might see a substantial advantage in bottom-line trajectory.

5Y net income/share CAGR above 1.5x OBE's 35.78%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.

3Y net income/share CAGR 1.25-1.5x OBE's 73.72%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.

Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.

Positive 5Y equity/share CAGR while OBE is negative. John Neff might see a clear edge in retaining earnings or managing capital better.

Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.

Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.

Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.

Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.

Our AR growth while OBE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.

Inventory is declining while OBE stands at 31.25%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.

Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.

Positive BV/share change while OBE is negative. John Neff sees a clear edge over a competitor losing equity.

We’re deleveraging while OBE stands at 2.23%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.

No Data available this quarter, please select a different quarter.